top of page
TAGS
Rheumatology
Trust Me, I'm Artificial Intelligence - The Roles of AI in Rheumatoid Arthritis
People at Increased Risk of Rheumatoid Arthritis Patients with RA often experience a reduced quality of life in several domains, such as physical health, level of independence, environment, and personal beliefs, compared with the healthy population ...
Jun 13, 2023
Pay Attention to Cardiovascular Risks in Patients with Autoimmune Disorders
Autoimmune disorders, such as rheumatoid arthritis, psoriasis, systemic sclerosis, lupus erythematosus, and type 1 diabetes, were found to be linked with increased CV risks, with risk dependent on the types of autoimmune disorders. In a population-b...
Jun 13, 2023
Artificial Intelligence-powered Flare Risk Prediction in Managing Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease that can create joint damage and bone destruction, causing severe pain and disability. The disease also manifests as extra-articular disease, that can affect most organs of the body, with a...
Aug 11, 2023
Novel Technology Stimulating Anti-inflammatory Response for Colitis Treatment
Despite the medical advancement in treating inflammatory bowel disease (IBD), the long-term therapeutic efficacy of these treatments remains questionable due to the severity of adverse effects. Laying on the intestinal epithelial cells is a Glycocal...
Oct 24, 2023
Biological Changes Happen Long Before IBD Becomes Symptomatic
Inflammatory bowel disease (IBD) has a higher prevalence in developed western countries than in East Asia, with about 120 to 200 cases per 100,000 for ulcerative colitis (UC) and 50 to 200 cases per 100,000 for Crohn¡¦s Disease (CD) in ...
Dec 18, 2023
Cibinqo
Cibinqo (abrocitinib) Pfizer Composition: Each film-coated tablet contains 50mg or 100 mg or 200 mg of abrocitinib. Indications: Cibinqo is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with refractory, moderate-to-severe ...
Dec 18, 2023
The True Powers of Vitamin B12 in Ulcerative Colitis
Many processes of tissue injury and repair in adult organs proceed through a transient dedifferentiation to a more developmentally primitive state. Recent studies have suggested vitamin B12 administration during an injury may promote cell plasticity...
Dec 18, 2023
A New Chapter of Giant Cell Arteritis Treatment with Upadacitinib
Giant cell arteritis (GCA), also known as temporal arteritis is a chronic inflammatory vasculitis that predominately affects large- and medium-sized arteries in individuals above the age of 50. More notably, GCA affects the cranial branches of the c...
Aug 20, 2024
The Role of Matrix Metalloproteases in Tendinopathy and Its Clinical Implications
Tendinopathies are generally referred to as conditions including chronic pain and rupture in tendons. Since inflammatory cells are usually absent in the lesion, tendinopathy has long been recognised as a degenerative condition. Accordingly, anti-inf...
Aug 20, 2024
Gain Without Pain – Revisiting the Pain Management in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease that initially affects small joints, and gradually involves larger joints with varying degree of severity. Apart from joint damage and bony erosion, pain is a common a...
Oct 22, 2024
Rheumatology in 2025: Breakthroughs, Technologies, and the Future of Care
The field of rheumatology has undergone transformative changes in 2025, driven by innovations in biologic therapies, precision medicine, digital health, and neuroimmune modulation. This article explores the most significant advances in the diagnosis...
Oct 24, 2025
SPEVIGO®
SPEVIGO ® (spesolimab) PFIZER HK Reg. No. HK-68915 (03 Dec, 2025) Composition: 2 For subcutaneous use: Injection: 150 mg/mL in a single-dose prefilled syringe Indication: 2 SPEVIGO ® is an interleukin-36 receptor antagonist indicated for the...
Feb 11, 2026
POPULAR STORY

Uncovering the Tricks of the Silent Thief of Sight
Dr. Roy Lau
Dec 19, 2024

What’s New in Coronary Artery Disease?
Dr. Roy Lau
Aug 20, 2024

Challenges and Strategies for Managing CHB Patients with Co-morbidities
Dr. Roy Lau
Jun 21, 2024

Decoding the Paradox on Impact of Obesity on Cognitive Functioning
Dr. Roy Lau
Jun 20, 2024

Gain Without Pain – Revisiting the Pain Management in Rheumatoid Arthritis
Dr. Roy Lau
Oct 22, 2024

Uncovering the Art of Perfect Matching – A Review on Precision Oncology
Dr. Roy Lau
Feb 17, 2025
bottom of page
.png)